Regulation of Wound Healing
and Organogenesis
Inventors:
Meenhard
Herlyn and Jiri Kalabis
Tech
ID: HM-0101, HM-00001
Description:
The growth and reconstruction of skin and other tissues
is a highly complex process that requires the appropriate support
structure (scaffolding) as well as the appropriate sequence of
induction of growth factors to stimulate epidermal, keratinocytic,
and immune cells. Wistar scientists have developed an organotypic
model for vascularized human skin. This model has been very useful
to delineate the changes in gene expression that occurs during
pathological and healing-associated changes of skin, colon, and
other tissues. Using this system, Wistar researchers are systematically
identifying the various genes, gene combinations, and scaffolding
cells that will optimally support skin and organ reconstruction.
Recently this system has
been utilized to establish other organotypic cultures, such as
a colonic reconstruct. The colonic reconstruct more closely mimics
in vivo functions of normal colon than cultured colonic cells.
This system may be of particular use for measuring drug absorption
and uptake in the gut.
Key Words:
Tissue engineering, wound healing, therapeutic, gene expression,
RNA expression, microarray, screening, screen, drug absorption,
research tool
Applications
and Advantages:This technology can be used to determine
and deliver the genes necessary to support the growth of new skin
and other tissues such as colon, breast, and pancreas.
Intellectual
Property Status: This technology is described in PCT/US01/31555
and additional pending patent applications.
Licensing
Opportunity: This technology is available for licensing
or for sponsored research support.
Contact:
Meryle
J. Melnicoff
Director, Business Development
The Wistar Institute
3601 Spruce Street
Philadelphia, PA 19104
Phone: (215) 898-0049
Fax: (215) 573-2456
melnicoff@wistar.org
Last Updated: Aug-02